Momenta Phamaceuticals, Inc. (MNTA) Misses Q4 FFO by 7c
Tweet Send to a FriendGet Alerts MNTA Hot Sheet
Price: $14.41 --0%
EPS Growth %: -380.0%
Financial Fact:
Research and development revenue: 2.21M
Today's EPS Names:
ATU, CRWS, CLC, More
EPS Growth %: -380.0%
Financial Fact:
Research and development revenue: 2.21M
Today's EPS Names:
ATU, CRWS, CLC, More
Trade MNTA Now!
Momenta Phamaceuticals, Inc. (NASDAQ: MNTA) reported Q4 FFO of $0.20, $0.07 worse than the analyst estimate of $0.27.
For earnings history and earnings-related data on Momenta Phamaceuticals, Inc. (MNTA) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Momenta Phamaceuticals, Inc. (MNTA) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- WallachBeth Capital Starts Momenta Pharmaceuticals (MNTA) at Buy
- UPDATE: Citi Raises PT on Micron Technology (MU) to $19
- PVH Corp. (PVH) Tops Q1 EPS by 56c; Issues Q2 EPS, Revs Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
